Neurim Pharmaceuticals

Neurim Pharmaceuticals Ltd. (www.neurim.com) is a neuroscience drug discovery and development company. Its first approved drug CIRCADIN®, is approved for patients over the age of 55 who are suffering from insomnia, and is commercially available in 45 countries around the world including Europe, Asia-Pacific, Latin America, Africa and the Middle East. Neurim has a strong and innovative product pipeline targeting diseases such as insomnia, Alzheimer's disease, dementia, and pain.